Skip to main content
. 2013 Oct 2;13:450. doi: 10.1186/1471-2407-13-450

Figure 9.

Figure 9

Immunoblots of PANC-1 and MiaPaCa-2 cells show degradation of the target Sirt1 upon cambinol treatment.